Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prurisol for Mild to Moderate Chronic Plaque Psoriasis
NCT02494479Phase 2Completed
- Sponsor
- Innovation Pharmaceuticals Inc.
- Start
- Aug 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Abacavir hydroxyacetate in plaque psoriasis, sponsored by Innovation Pharmaceuticals Inc.. Started Aug 2015; status: completed.
02
Drugs
Abacavir hydroxyacetate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02494479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494479.